当前位置：
X-MOL 学术
›
J Law Biosci
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19.
Journal of Law and the Biosciences ( IF 2.5 ) Pub Date : 2020-11-19 , DOI: 10.1093/jlb/lsaa083 Sterling Edmonds 1 , Andrea MacGregor 1 , Agnieszka Doll 1 , Ipek Eren Vural 1 , Janice Graham 2 , Katherine Fierlbeck 3 , Joel Lexchin 4 , Peter Doshi 5 , Matthew Herder 1
中文翻译：
透明度太少，来不及？面对COVID-19，加拿大卫生部为何以及如何使临床数据和监管决策受到审查。
更新日期：2020-11-19
Journal of Law and the Biosciences ( IF 2.5 ) Pub Date : 2020-11-19 , DOI: 10.1093/jlb/lsaa083 Sterling Edmonds 1 , Andrea MacGregor 1 , Agnieszka Doll 1 , Ipek Eren Vural 1 , Janice Graham 2 , Katherine Fierlbeck 3 , Joel Lexchin 4 , Peter Doshi 5 , Matthew Herder 1
Affiliation
中文翻译：
透明度太少，来不及？面对COVID-19，加拿大卫生部为何以及如何使临床数据和监管决策受到审查。
京公网安备 11010802027423号